Hepatic, Metabolic, and Nutritional Disorders of Alcoholism: From Pathogenesis to Therapy

References

• Chedid A, Mendenhall CL, Garside P, et al: Prognostic factors in alcoholic liver disease. Am J Gastroenterol 1991;82:210–16.
   Google Scholar
• Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine 1962;41:249–76.
   PubMed Web of Science ®Google Scholar
• Lieber CS: Pathogenesis and natural course of alcoholic liver disease. In: R Schmid, L Bianchi, HE Blum, W Gerok, KP Maier and GA Stalder, editors. Acute and Chronic Liver Disease: Molecular Biology and Clinics. Symposium No. 87. Section III: Toxic Liver Diseases, Lancaster, UK: Kluwer Academic Publishers; 1996. Chap 9, p. 109–25.
   Google Scholar
• Lieber CS, Jones DP, DeCarli LM. Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J Clin Invest 1965;44:1009–21.
   PubMed Web of Science ®Google Scholar
• Lane BP, Lieber CS. Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol 1966;49:593–603.
   PubMed Web of Science ®Google Scholar
• Worner TM, Lieber CS: Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 1985;254:627–30.
   PubMedGoogle Scholar
• Hasumura Y, Minato Y, Nishimura M, et al. Hepatic fibrosis in alcoholics: Morphologic characteristics, clinical diagnosis, and natural course. Pathobiol Hepatic Fibrosis. 1985;7:13–24.
   Google Scholar
• Lieber CS, DeCarli LM, Rubin E. Sequential production of fatty liver, hepatitis and cirrhosis in sub-human primates fed ethanol with adequate diets. Proc Natl Acad Sci, USA. 1975;72:437–41.
   PubMed Web of Science ®Google Scholar
• Lieber CS, DeCarli LM, Mak KM, et al. Attenuation of alcohol-induced hepatic fibrosis by polyunsaturated lecithin. Hepatology 1990;12:1390–8.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Robins SJ, Leo MA: Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol: Clin Exp Res 1994;18:592–5.
   PubMed Web of Science ®Google Scholar
• Mak KM, Lieber CS: Portal Fibroblasts and myofibroblasts in baboons after long-term alcohol consumption. Arch Pathol Lab Med 1986;110:513–16.
   PubMedGoogle Scholar
• Mak KI, Lieber CS. Lipocytes and transitional cells in alcoholic liver disease: a morphometric study. Hepatology 1988;8:1027–33.
   PubMed Web of Science ®Google Scholar
• Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation of lipocytes to transitional cells. Gastroenterology 1984; 87: 188–200.
   PubMed Web of Science ®Google Scholar
• Friedman SL. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies N Engl J Med 1993;328:1828–35.
   Google Scholar
• Moshage H, Casini A, Lieber CS. Acetaldehyde selectively stimulates collagen production in cultured rat liver-storing cells but not in hepatocytes. Hepatology 1990;12:511–18.
   PubMed Web of Science ®Google Scholar
• Kyosola K, Salorinne Y. Liver biopsy and liver function tests in 28 consecutive long-term alcoholics. Ann Clin Res. 1975;7:80–4.
   PubMedGoogle Scholar
• Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann NY Acad Sci. 1975;252:85–105.
   PubMed Web of Science ®Google Scholar
• Sorensen TIA, Orholm M, Bentsen KD, et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in man as predictors of development of cirrhosis. Lancet. 1984; ii: 241–4.
   Google Scholar
• Svoboda DJ, Manning RT. Chronic alcoholism with fatty metamorphosis of the liver. Am J Pathol. 1964;44:645–62.
   PubMed Web of Science ®Google Scholar
• Edmondson HA, Peters RL, Frankel HH, et al. The early stage of liver injury in the alcoholic. Medicine. 1967;46:119–29.
   PubMed Web of Science ®Google Scholar
• Klion FM, Schaffner F. Ultrastructural studies in alcoholic liver disease. Digestion. 1968;1:2–14.
   PubMed Web of Science ®Google Scholar
• Rubin E, Popper H. The evolution of human cirrhosis deduced from observations in experimental animals. Medicine. 1967;46:163–83.
   PubMed Web of Science ®Google Scholar
• Goodman ZD, Ishak KG. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 1982;93-403.
   Google Scholar
• Van Waes L, Lieber CS. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 1977;73:646–50.
   PubMedGoogle Scholar
• Mak KM, Lieber CS. Alterations in endothelial fenestrations in liver sinusoids of baboons fed alcohol: a scanning electron microscopic study. Hepatology 1984;4:386–91.
   PubMedGoogle Scholar
• Bell ET. Relation of portal cirrhosis to hemochromatosis and to diabetes mellitus. Diabetes. 1955;4:435–46.
   PubMedGoogle Scholar
• Powell LW. The role of alcoholism in hepatic iron storage disease. Ann NY Acad Sci 1975;252:124–34.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Seitz HK, Garro AJ, et al: Alcohol related diseases and carcinogenesis. Cancer Res 1979;39:2863–86.
   PubMed Web of Science ®Google Scholar
• Volpicelli JR, Alterman AI, Hayashida M, et al. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876–80.
   PubMed Web of Science ®Google Scholar
• O'Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 1992;49:881–7.
   PubMed Web of Science ®Google Scholar
• Besson J, Aeby F, Kasas A, et al. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: A controlled study. Alcohol: Clin Exp Res 1998;22:573–9.
   PubMed Web of Science ®Google Scholar
• Lieber CS: Medical and Nutritional Complications of Alcoholism: Mechanisms and Management, New York, Plenum Press, pp 579, 1992.
   Google Scholar
• Lieber CS. Hepatic, metabolic and toxic effects of ethanol: 1991 update. Alcohol: Clin Exp Res 1991;15:573–92.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Jones DP, Mendelson J, et al. Fatty liver, hyperlipemia and hyperuricemia produced by prolonged alcohol consumption, despite adequate dietary intake. Trans Assoc Am Phys 1963;76:289–300.
   Google Scholar
• DeCarli LM, Lieber CS. Fatty liver in the rat after prolonged intake of ethanol with a nutritionally adequate new liquid diet. J Nutr 1967;91:331–6.
   PubMed Web of Science ®Google Scholar
• Lieber CS, DeCarli LM. An experimental model of alcohol feeding and liver injury in the baboon. J Med Primatol 1974;3:153–63.
   PubMed Web of Science ®Google Scholar
• Lieber CS: Hepatic and other Medical Disorders of Alcoholism: From Pathogenesis to Treatment. J Stud Alcohol 1998;59:9–25
   PubMed Web of Science ®Google Scholar
• Lumeng L, Li T-K. Vitamin B6 metabolism in chronic alcohol abuse. J Clin Invest 1974;53:693-704. 6
   Google Scholar
• Fonda ML, Brown SG, Pendleton MW. Concentration of vitamin B6 and activities of enzymes of B6 metabolism in the blood of alcoholic and nonalcoholic men. Alcohol: Clin Exp Res 1989;3:804–9.
   Google Scholar
• Lumeng LJ. The role of acetaldehyde in mediating the deleterious effect of ethanol on pyridoxal 5'-phosphate metabolism. J Clin Invest 1978;62:286–93.
   PubMedGoogle Scholar
• Vech RL, Lumeng L, Li TK. Vitamin B6 metabolism in chronic alcohol abuse. The effect of ethanol oxidation on hepatic pyridoxal 5'-phosphate metabolism. J Clin Invest 1975;55: 102632.
   Google Scholar
• Parker TH, Marshall JP, Roberts RK, et al. Effect of acute alcohol ingestion on plasma pyridoxal 5'-phosphate. Am J Clin Nutr 1979;32:1246–52.
   PubMed Web of Science ®Google Scholar
• Lumeng L, Schenker S, Li T-K, et al. Clearance and metabolisms of plasma pyridoxial 5' phosphate in the dog. J Lab Clin Med 1984;103:59–64.
   PubMedGoogle Scholar
• Kinsell L, Harper HA, Barton HC, et al. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science 1947;106:589–94.
   Web of Science ®Google Scholar
• Horowitz JH, Rypins EB, Henderson JM, et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology 1981;81:668–75.
   PubMed Web of Science ®Google Scholar
• Duce AM, Ortiz P, Cabrero C, et al. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988;8:65–8.
   PubMed Web of Science ®Google Scholar
• Lieber CS. Alcoholic Liver Disease: New insights in pathogenesis lead to new treatments. J Hepatology 2000;32:113–28.
   PubMed Web of Science ®Google Scholar
• Lu SC. Methionine adenosyltransferase and liver disease: It's all about SAM. Gastroenter-ology 1998;114:403–7.
   PubMedGoogle Scholar
• Avila MA, Carretero V, Rodriguez N, et al. Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology 1998;114:364–71.
   PubMedGoogle Scholar
• Lieber CS, Casini A, DeCarli LM, et al. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology 1990;11:165–72.
   PubMed Web of Science ®Google Scholar
• Hirata F, Axelrod J. Phospholipid methylation and biological signal transmission. Science 1980;209:1082–90.
   PubMed Web of Science ®Google Scholar
• Hirata F, Viveros OH, Diliberto EJ Jr, et al. Identification and properties of two methyltransferases in conversion of phosphatidylethanolamine to phosphatidylcholine. Proc Natl Acad Sci 1978;75:1718–21.
   PubMed Web of Science ®Google Scholar
• Yamada S, Mak KM, Lieber CS. Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology 1985;88:1799–806.
   PubMed Web of Science ®Google Scholar
• Stramentinoli G, Gualano M, Galli-Kienle G. Intestinal absorption of S-adenosyl-L-methion-ine. J Pharmacol Exp Ther 1979;209:323–26.
   PubMedGoogle Scholar
• Bornbardieri G, Pappalardo G, Bernardi L, et al. Intestinal absorption of S-adenosyl-L-methionine in humans. Int J Clin Pharmacol, Therapy Toxicol 1983;21:186–8.
   PubMedGoogle Scholar
• Hoffinan DR, Marion DW, Cornatzer WE, et al. S-adenosylmethionine and S-adenosylhomocysteine metabolism in isolated rat liver. J Biol Chem 1980;255:10822–7.
   PubMedGoogle Scholar
• Travers J, Varela I, Mato JM. Effect of exogenous S-adenosyl-L-methionine on phosphatidylcholine synthesis by isolated rat hepatocytes. Biochem Pharmacol 1984;33:1562–4.
   PubMedGoogle Scholar
• Pezzoli C, Stramentinoli G, Galli-Kienele M, et al. Uptake and metabolism of S-adenosyl-L-methionine by isolated rat hepatocytes. Biochem Biophys Res Commun 1978;85:1031–8.
   PubMedGoogle Scholar
• Engstrom MA, Benevenga NJ. Rates of oxidation of the methionine and S-adenosylmethionine methyl carbons in isolated rat hepatocytes. J Nutr 1987;117:1820–6.
   PubMedGoogle Scholar
• Giudici GA, Le Grazie C, Di Padova C. The use of ademethionine (SAMe) in the treatment of cholestatic liver disorders: meta-analysis of clinical trials. In: Mato JM, Lieber C, Kaplowitz N, Caballero A, editors. Methionine Metabolism: Molecular Mechanism and Clinical Implications. Madrid: CSIC Press 1992;67-79.
   Google Scholar
• Frezza M, Pozzato G, Chiesa L, et al. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology 1984;4:274–8
   PubMed Web of Science ®Google Scholar
• Frezza M, Surrenti C, Manzillo G, et al. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis: a double-blind placebo controlled study. Gastroenterology 1990;99:211–15.
   PubMed Web of Science ®Google Scholar
• Vendemiale G, Altomare E, Trizio T, et al. Effect of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol 1989;24:407–15.
   PubMed Web of Science ®Google Scholar
• Mato JM, Camara J, Fernandez de Paz J, et al. S-Adenosylmethionine in alcoholic liver cirrhosis: A randomized, placebo-controlled, double-blind, multicentre clinical trial. J Hepatology 1999;30:1081–9.
   Google Scholar
• Lieber CS, Robins SJ, Li J, et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology 1994;106:152–9.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Leo MA, Mak KM, et al. Choline fails to prevent liver fibrosis in ethanol-fed baboons but causes toxicity. Hepatology 1985;5:561–72.
   PubMed Web of Science ®Google Scholar
• Zeisel S, Busztajn JK. Choline and human nutrition. Annu Rev Nutr 1994;14:269–96.
   PubMed Web of Science ®Google Scholar
• Lekim D, Graf E. Tierexperimentelle Studien zur Pharmakokinetik der 'essentiellen' Phospholipide (EPL). Drug Research-Arzneimittel-Forschung 1976;26:1772–82.
   PubMedGoogle Scholar
• Zern MA, Leo MA, Giambrone MA, et al. Increased type I procollagen mRNA levels and in vitroprotein synthesis in the baboon model of chronic alcoholic liver disease. Gastroenterology 1985;89:1123–31.
   PubMed Web of Science ®Google Scholar
• Poniachik J, Baraona E, Zhao J, et al. Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation. J Lab Clin Med 1999;133:342–8.
   PubMedGoogle Scholar
• Arai M, Leo MA, Nakano M, et al: Biochemical and morphological alterations of baboon hepatic mitochondria after chronic ethanol consumption. Hepatology 1984;4:165–74.
   PubMed Web of Science ®Google Scholar
• Arai M, Gordon ER, Lieber CS. Decreased cytochrome oxidase activity in hepatic mitochondria after chronic ethanol consumption and the possible role of decreased cytochrome aa3 content and changes in phospholipids. Biochim Biophys Acta 1984;797:320–7.
   PubMedGoogle Scholar
• Navder KP, Baraona E, Lieber CS: Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J Nutr 1997;127:1800–06.
   PubMed Web of Science ®Google Scholar
• Hoek JB, Thomas AP, Rooney TA, et al. Ethanol and signal transduction in the liver. Fed Am Soc Exp Bio J 1992;6:2386–96.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Leo MA, Aleynik SI, et al. Polyenylphosphatidylcholine decreases alcohol-induced oxidative stress in the baboon. Alcohol: Clin Exp Res 1997;21:375–9.
   PubMed Web of Science ®Google Scholar
• Ma X, Zhao J, Lieber CS: Polyenylphosphatidylcholine attenuates non-alcoholic hepatic fibrosis and accelerates its regression. J Hepatology 1996;24:604–13.
   PubMed Web of Science ®Google Scholar
• Li J-J, Kim C-I, Leo MA, et al: Polyunsaturated lecithin prevents acetaldehyde-mediated hepatic collagen accumulation by stimulating collagenase activity in cultured stellate cells. Hepatology 1992;15:373–81.
   PubMed Web of Science ®Google Scholar
• Niederau C, Strohmeyer G, Heinges T, et al. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double blind, placebo-controlled trial. Hepato Gastroenterol 1998;45:797–804.
   PubMedGoogle Scholar
• Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: Adverse interactions, including hepatotoxicity and carcinogenicity. Amer J Clin Nutr 1999;69:1071–85.
   PubMed Web of Science ®Google Scholar
• Leo MA, Lieber CS: Interaction of ethanol with vitamin A. Alcoholism: Clin Exp Res 1983;7:15–21.
   PubMedGoogle Scholar
• Leo MA, Lieber CS: Hepatic vitamin A depletion in alcoholic liver injury. N Engl J Med 1982;307:597–601.
   PubMed Web of Science ®Google Scholar
• Sato M, Lieber CS: Hepatic vitamin A depletion after chronic ethanol consumption in baboons and rats. J Nutr 1981;111:2015–23.
   PubMed Web of Science ®Google Scholar
• Sato M, Lieber CS: Changes in vitamin A status after acute ethanol administration in the rat. I Nutr 1982;112:1188–96.
   PubMed Web of Science ®Google Scholar
• Sato M, Lieber CS: Increased metabolism of retinoic acid after chronic ethanol consumption in rat liver microsomes. Arch Biochem Biophys 1982;213:557–64.
   PubMed Web of Science ®Google Scholar
• Leo MA, Lowe N, Lieber CS: Decreased hepatic vitamin A after drug administration in men and in rats. Am J Clin Nutr 1984;40:1131–6.
   PubMed Web of Science ®Google Scholar
• Reddy TV, Weisburger EK. Hepatic vitamin A status of rats during feeding of hepatocarcinogen 2-aminoanthrequinone. Cancer Lett 1980;10:39–44.
   PubMedGoogle Scholar
• Leo MA, Lowe N, Lieber CS. Potentiation of ethanol-induced hepatic vitamin A depletion by phenobarbital and butylated hydroxytoluene. J Nutr 1987;117:70–6.
   PubMed Web of Science ®Google Scholar
• Roberts AB, Lamb LC, Spron MB. Metabolism of all-trans-retinoic acid in hamster liver microsomes: Oxidation of 4-hydroxy-to 4-keto retinoic acid. Arch Biochem Biophys 1980;234:374–83.
   Google Scholar
• Leo MA, Iida S, Lieber CS. Retinoic acid metabolism by a system reconstituted with cytochrome P-450. Arch Biochem Biophys 1984;234:305–12.
   PubMed Web of Science ®Google Scholar
• Leo MA, Lieber CS. New pathway for retinol metabolism in liver microsomes. J Biol Chem 1985;260:5228–31.
   PubMed Web of Science ®Google Scholar
• Tomita S, Okuyama E, Ohnishi T, et al. Characteristic properties of a retinoic acid synthetic cytochrome P-450 purified from liver microsomes of 3-methylcholanthrene-induced rats. Biochimica Biophys Acta 1996;1290:273–81.
   PubMedGoogle Scholar
• Leo MA, Kim C, Lieber CS: NAD+-dependent retinol dehydrogenase in liver microsomes. Arch Biochem Biophys 1987;259:241–9.
   PubMed Web of Science ®Google Scholar
• Leo MA, Lasker JM, Raucy JL, et al: Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys 1989;269:305–12.
   PubMed Web of Science ®Google Scholar
• Leo MA, Sato M, Lieber CS: Effect of hepatic vitamin A depletion on the liver in humans and rats. Gastroenterology 1983;84:562–72.
   PubMed Web of Science ®Google Scholar
• Leo MA, Arai M, Sato M, et al: Exacerbation by ethanol of liver injury due to vitamin A deficiency and excess. In: CS Lieber, editor. Biological Approach to Alcoholism: Update. Research Monograph-11, DHHS Publication No. (ADM) 83-1261, Superintendent of Documents, Washington, DC: US Government Printing Office; 1983. p. 195–233
   Google Scholar
• Davis BH, Vucic A. The effect of retinol on Ito cell proliferation in vitro. Hepatology 1988;8:788–93.
   PubMedGoogle Scholar
• Davis BH, Kramer RJ, Davidson NO. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor P production. J Clin Invest 1990;86:2062–70.
   PubMedGoogle Scholar
• Friedman SL, Wei S, Blaner W. Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF. Am J Physiol 1993;264:G947–52.
   PubMedGoogle Scholar
• Sporn M.B. Prevention of epithelial cancer by vitamin A and its synthetic analogs. In: Hiatt, H.H.; Watson, J.D.; and Winsten, J.A., eds. Origins of Human Cancer. New York: Cold Spring Harbor, 1977. p. 801–807.
   Google Scholar
• Kark JS, Smith AH, Switzer BR, et al. Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Natl Cancer Inst 1981;66:7–16.
   PubMed Web of Science ®Google Scholar
• Mak KM, Leo MA, Lieber CS: Potentiation by ethanol consumption of tracheal squamous metaplasia caused by vitamin A deficiency in rats. J Natl Cancer Inst 1987;79:1001–10.
   PubMedGoogle Scholar
• Leo MA, Lowe N, Lieber CS. Interaction of drugs and retinol. Biochem Pharmacol 1986;35:3949–53.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu C, Chung J, et al. Chronic alcohol intake reduces retinoic acid concentration and enhances AP-1 (c-Jun and c-Fos) Expression in rat liver. Hepatology 1998;28:744–50.
   PubMed Web of Science ®Google Scholar
• Duester G. Alcohol dehydrogenase as a critical mediator of retinoic acid synthesis from vitamin a in the mouse embryo. J Nutr 1998;128:459S–462S.
   Google Scholar
• Haselbeck RJ, Duester G. Regional restriction of alcohol/retinol dehydrogenases along the mouse gastrointestinal epithelium. Alcohol: Clin Exp Res 1997;21:1484–90.
   PubMedGoogle Scholar
• Russell RM, Boyer JL, Bagheri SA, et al. Hepatic injury from chronic hypervitaminosis A resulting in portal hypertension and ascites. N Engl J Med 1974;291:435–40.
   PubMed Web of Science ®Google Scholar
• Farrell GC, Bathal PS, Powell LW. Abnormal liver function in chronic hypervitaminosis A. Dig Dis Sci 1977;22:724–8.
   Google Scholar
• Geubel AP, DeGalocsy C, Alves N, et al. Liver damage caused by therapeutic vitamin A administration: estimate of dose related toxicity in 41 cases. Gastroenterology 1991;100:1701–9.
   PubMed Web of Science ®Google Scholar
• Leo MA, Arai M, Sato M, et al. Hepatotoxicity of vitamin A and ethanol in the rat. Gastroenterology 1982;82:194–205.
   PubMed Web of Science ®Google Scholar
• Worner TM, Gordon G, Leo MA, et al. Treatment with vitamin A of sexual dysfunction in male alcoholics. Am J Clin Nutr 1988;48:1431–5.
   PubMedGoogle Scholar
• Minuk GY, Kelly JK, Hwang WS. Vitamin A hepatoxicity in multiple family members. Hepatology 1988; 8: 272–5.
   PubMedGoogle Scholar
• Leo MA, Lieber CS: Hypervitaminosis A: A liver lover's lament. Hepatology 1988;8: 41217.
   Google Scholar
• Ahmed S, Leo MA, Lieber CS: Interactions between alcohol and beta-carotene in patients with alcoholic liver disease. Am J Clin Nutr 1994;60:430–6.
   PubMed Web of Science ®Google Scholar
• Ward RJ, Peters TJ: The antioxidant status of patients with either alcohol-induced liver damage or myopathy. Alcohol Alcoholism 1992;27:359–65.
   PubMed Web of Science ®Google Scholar
• Forman MR, Beecher GR, Lanza E, et al. Effect of alcohol consumption on plasma carotenoid concentrations in premenopausal women: A controlled dietary study. Am J Clin Nutr 1995;62:131–5.
   PubMed Web of Science ®Google Scholar
• Leo MA, Kim CI, Lowe N, et al. Interaction of ethanol with P-carotene: Delayed blood clearance and enhanced hepatotoxicity. Hepatology 1992;15:883–91.
   PubMed Web of Science ®Google Scholar
• Leo MA, Aleynik SI, Aleynik MK, et al. P-carotene beadlets potentiate hepatotoxicity of alcohol. Am J Clin Nutr 1997;66:1461–9.
   PubMedGoogle Scholar
• a-Tocopherol, P-carotene and Cancer Prevention Study Group. The effect of vitamin E and P-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029–35.
   PubMed Web of Science ®Google Scholar
• Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–5.
   PubMed Web of Science ®Google Scholar
• Leo MA, Lieber CS. Beta carotene, vitamin E, and lung cancer. N Engl J Med 1994;331: 612 (letter)
   Google Scholar
• Garro AJ, Gordon BHJ, Lieber CS. Alcohol Abuse: Carcinogenic effects and fetal alcohol syndrome. IN: Medical and Nutritional Complications of Alcoholism: Mechanisms and Management, C.S. Lieber Editor, New York, Plenum Press, 1992; p. 459.
   Google Scholar
• Paolini M, Forti GC, Perocco P, et al. Co-carcinogenic effect of P-carotene. Nature 1999;398:760–1.
   PubMed Web of Science ®Google Scholar
• Jewell C, O'Brien N. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Brit J Nutr 1999;81:235–42.
   PubMed Web of Science ®Google Scholar
• Burton GW and Ingold KU: P-carotene: An unusual type of lipid antioxidant. Science 1984;224:569–73.
   PubMed Web of Science ®Google Scholar
• Lowe GM, Booth LA, Young AJ, et al. Lycopene and P-carotene protect against oxidative damage in HT29 cells at low concentrations but rapidly lose this capacity at higher doses. Free Rad Res 1999;30:141–51.
   PubMed Web of Science ®Google Scholar
• Woods JA, Bilton RF, Young AJ. P-carotene enhances hydrogen peroxide-induced DNA damage in human hepatocellular Hep G2 cells. FEBS Lett 1999; 449: 255–8.
   PubMedGoogle Scholar
• Albanes D, Heinonen OP, Taylor PR, et al. a-tocopherol and B-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996;88:1560–71.
   PubMed Web of Science ®Google Scholar
• Omenn GS, Goodman GE, Thornquist MD, et al. Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 1996;88:1550–9.
   PubMed Web of Science ®Google Scholar
• Albanes D, Virtamo J, Taylor PR, et al. Effects of supplemental P-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the alpha tocopherol, beta-carotene cancer prevention study. Am J Clin Nutr 1997;66:366–72.
   PubMed Web of Science ®Google Scholar
• Baraona E, Julkunen R, Tannenbaum L, et al. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 1986;90:103–10.
   PubMed Web of Science ®Google Scholar
• Bjorkhem I. On the role of alcohol dehydrogenase in m-oxidation of fatty acids. Eur J Biochem 1972;30:441–51.
   PubMedGoogle Scholar
• Faller J, Fox IH. Evidence for increased urate production by activation of adenine nucleotide turnover. N Engl J Med 1982;307:1598–602.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Schmid R: The effect of ethanol on fatty acid metabolism: Stimulation of hepatic fatty acid synthesis in vitro. Clin Invest 1961;40:394–9.
   Google Scholar
• Lieber CS. Cytochrome P4502E1: Its physiological and pathological role. Physiol Rev 1997;77:517–44.
   PubMed Web of Science ®Google Scholar
• Lieber CS. Microsomal ethanol-oxidizing system (MEOS), the first 30 years (1968-1998)-a review. Alcohol: Clin Exp Res 1999;23:991–1007.
   PubMed Web of Science ®Google Scholar
• Meldolesi J: On the significance of the hypertrophy of the smooth endoplasmic reticulum in liver cells after administration of drugs. Biochem Pharmcol, 1967;16:125–31.
   Google Scholar
• Conney AH: Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 1967;19:317–66.
   Google Scholar
• Lane BP, Lieber CS: Effects of butylated hydroxytoluene on the ultrastructure of rat hepato-cytes. Lab Invest 1967;16:341–8.
   Google Scholar
• Lieber CS, DeCarli LM: Ethanol oxidation by hepatic microsomes: Adaptive increase after ethanol feeding. Science 1968;162:917–8.
   PubMed Web of Science ®Google Scholar
• Lieber CS, DeCarli LM. Hepatic microsomal ethanol oxidizing system: In vitro characteristics and adaptive properties in vivo, J Biol Chem 1970;245:2505–12.
   Google Scholar
• Ohnishi K, Lieber CS. Reconstitution of the microsomal ethanol-oxidizing system: qualitative and quantitative changes of cytochrome P-450 after chronic ethanol consumption, J Biol Chem 1977;252:7124–31.
   Google Scholar
• Miwa GT, Levin W, Thomas PE, et al. The direct oxidation of ethanol by catalase- and alcohol dehydrogenase-free reconstituted system containing cytochrome P-450, Arch Biochem Biophys 1978;187:464–75.
   Google Scholar
• Koop DR, Morgan ET, Tarr GE, et al. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits, J Biol Chem 1982;257:8472–80.
   Google Scholar
• Lasker JM, Raucy J, Kubota S, et al. Purification and characterization of human liver cytochrome P-450-ALC, Biochem Biophys Res Commun, 1987;148:232–8.
   PubMed Web of Science ®Google Scholar
• Tsutsumi M, Lasker JM, Shimizu M, et al. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 1989;10:437–46.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Lasker JM, Rosman AS, et al. Induction of P450E1 in human liver by ethanol is due to a corresponding increase in encoding mRNA. Hepatology 1993;17:236–45.
   PubMed Web of Science ®Google Scholar
• Salmela KS, Kessova IG, Tsyrlov IB, et al. Respective roles of human cytochrome P4502E1, 1A2, and 3A4 in the hepatic microsomal ethanol oxidizing system. Alcohol: Clin Exp Res 1998;22:2125–32.
   PubMed Web of Science ®Google Scholar
• Salaspuro MP, Lieber CS: Non-uniformity of blood ethanol elimination: its exaggeration after chronic consumption. Ann Clin Res 1978;10:294–7.
   PubMedGoogle Scholar
• Kater RMH, Tobon F, Iber FL. Increased rate of tolbutamide metabolism in alcoholic patients. JAMA 1969;207:363–5.
   PubMed Web of Science ®Google Scholar
• Kater RMH, Roggin G, Tobon F, et al. Increased rate of clearance of drugs from the circulation of alcoholics. Am J Med Sci 1969;258:35–9.
   PubMed Web of Science ®Google Scholar
• Misra PS, Lefevre A, Ishii H, et al. Increase of ethanol meprobamate and pentobarbital metabolism after chronic ethanol administration in man and in rats. Am J Med 1971;51: 34651.
   Google Scholar
• Sotaniemi EA, Anttila M, Rautio A, et al. Propranolol and sotaiol metabolism after a drinking party. Clin Pharmacol Ther 1981;29:705–10.
   PubMed Web of Science ®Google Scholar
• Hetu C, Joly J-G. Differences in the duration of the enhancement of liver mixed-function oxidase activities in ethanol-fed rats after withdrawal. Biochem Pharmacol 1985;34:1211–16.
   PubMed Web of Science ®Google Scholar
• Vessell ES, Page JG, Passananti GT. Genetic environmental factors affecting ethanol metabolism in man. Clin Pharmacol Ther 1971;12:192–201.
   PubMed Web of Science ®Google Scholar
• Carulli N, Manenti I, Gallo M, et al. Alcohol-drugs interaction in man: Alcohol and tolbuta-mide. Eur J Clin Invest 1971;1:421–4.
   PubMed Web of Science ®Google Scholar
• Pritchard JF, Schneck DW. Effects of ethanol and phenobarbital on the metabolism of propanolol by 9000 g rat liver supernatant. Biochem Pharmacol 1977;26:2453–4.
   PubMed Web of Science ®Google Scholar
• Sellman R, Kanto J, Raijola E, et al. Human and animal study on elimination from plasma and metabolism of diazepam after chronic alcohol intake. Acta Pharmacol Toxicol 1975;36: 338.
   Google Scholar
• Grassi GG, Grassi C. Ethanol-antibiotic interactions at hepatic level. J Clin Pharmacol Biopharmacol 1975;11:216–25.
   Web of Science ®Google Scholar
• Laethem RM, Balaxy M, Falck JR, et al. Formation of 19(S)-, 19(R)-, and 18(R)-Hyroxyeicosatetraenoic acids by alcohol-inducible cytochrome P4502E1. J Biol Chem 1993;268:12912–18.
   PubMed Web of Science ®Google Scholar
• Amet Y, Berthou F, Goasduff T, et al. Evidence that cytochrome P450 2E1 is involved in the (m-1)-hydroxylation of lauric acid in rat liver microsomes. Biochem Biophys Res Comm 1994;203:1168–74.
   PubMed Web of Science ®Google Scholar
• Adas F, Betthou F, Picart D, et al. Involvement of cytochrome P450 2E1 in the (omega-1)-hydroxylation of oleic acid in human and rat liver microsomes. J Lipid Res 1998;39: 12109.
   Google Scholar
• Koop DR, Casazza JP. Identification of ethanol-inducible P-450 isozyme 3a as the acetone and acetol monooxygenase of rabbit microsomes. J Biol Chem 1985;260:13607–12.
   PubMed Web of Science ®Google Scholar
• Koop DR, Crump BL, Nordblom GD, et al. Ummunochemical evidence for induction of the alcohol oxidizing cytochrome P450 isozyme 3a (P-450IIE1) as a benzene and phenol hydroxylase. Toxicol Appl Pharmacol 1989;98:278–88.
   PubMed Web of Science ®Google Scholar
• Yang CS, Yoo J-S, Ishizaki H, et al. Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab Rev 1990;22:147–59.
   PubMed Web of Science ®Google Scholar
• Raucy JL, Lasker JM, Kramer JC, et al. Induction of P450IIE1 in the obese rat. Molec Pharmacol 1991;39:275–80.
   PubMed Web of Science ®Google Scholar
• Weltman MD, Farrell GC, Hall P, et al. Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998;27:128–33.
   PubMed Web of Science ®Google Scholar
• Tsutsumi M, Leo MA, Kim C, et al. Interaction of ethanol with enflurane metabolism and toxicity: Role of P450IIE1. Alcohol: Clin Exp Res 1990;14:174–9.
   PubMed Web of Science ®Google Scholar
• Sato C, Nakano M, Lieber CS. Increased hepatotoxicity of acetaminophen after chronic ethanol consumption in the rat. Gastroenterology 1981;80:140–8.
   PubMed Web of Science ®Google Scholar
• Whitecomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845–50.
   PubMedGoogle Scholar
• Leo MA, Rosman A, Lieber CS. Differential depletion of carotenoids and tocopherol in liver diseases. Hepatology, 1993;17:977–86.
   PubMed Web of Science ®Google Scholar
• Casini A, Cunningham M, Rojkind M, et al. Acetaldehyde increases procollagen type I and fibronectin gene transcription in cultured rat fat-storing cells through a protein synthesis-dependent mechanism. Hepatology 1991;13:758–65.
   PubMed Web of Science ®Google Scholar
• Lieber CS, DeCarli LM. Reduced nicotinamide-adenine dinucleotide phosphate oxidase: Activity enhanced by ethanol consumption. Science 1970;170:78–80.
   PubMedGoogle Scholar
• Dai Y, Rashba-Step J, Cederbaum AI. Stable expression of human cytochrome P4502E1 in HepG2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 1993;32:6928–37.
   PubMed Web of Science ®Google Scholar
• Ekstrom G, Ingelman-Sundberg M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 1989;38:1313–19.
   PubMed Web of Science ®Google Scholar
• Castillo T, Koop DR, Kamimura S, et al. Role of cytochrome P-450 2E1 in ethanol-, carbon tetrachloride- and iron-dependent microsomal lipid peroxidation. Hepatology 1992;16:992–6.
   PubMed Web of Science ®Google Scholar
• Albano E, Tomasi A, Goria-Gatti L, et al. Free radical metabolism of alcohols in rat liver microsomes. Free Rad Res Commun 1987;3: 243.
   PubMedGoogle Scholar
• Reinke L, Lai EK, DuBose CM, et al. Reactive free radical generation in vivoin heart and liver of ethanol-fed rats: Correlation with radical formation in vitro. Proc Natl Acad Sci U.S.A., 1987;84:8223–7.
   Google Scholar
• Reinke LA, Kotake Y, McCay PB, et al. Spin trapping studies of hepatic free radicals formed following the acute administration of ethanol to rats: in vivo detection of l-hydroxyethyl radicals with PBN. Free Rad Biol Med 1991;11:31–9.
   PubMed Web of Science ®Google Scholar
• Koivisto T, Mishin VM, Mak KM, et al. Induction of cytochrome P-4502E1 by ethanol in rat Kupffer cells. Alcohol: Clin Exp Res 1996;20:207–12.
   PubMed Web of Science ®Google Scholar
• Muller A, Sies H. Role of alcohol dehydrogenase activity and of acetaldehyde in ethanol-induced ethane and pentane production by isolated perfused rat liver. Biochem J 1982;206:153–6.
   PubMed Web of Science ®Google Scholar
• Muller A, Sies H. Inhibition of ethanol- and aldehyde-induced release of ethane from isolated perfused rat liver by Pargyline and Disulfiram. Pharmacol Biochem Behav, 1983;18:429–32.
   PubMed Web of Science ®Google Scholar
• Shaw S, Rubin KP, Lieber CS. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: Evidence of lipid peroxidation. Dig Dis Sci 1983;28:585–9.
   PubMed Web of Science ®Google Scholar
• Morton S, Mitchell MC. Effects of chronic ethanol feeding on glutathione turnover in the rat. Biochem Pharmacol 1985;34:1559–63.
   PubMed Web of Science ®Google Scholar
• Speisky H, MacDonald A, Giles G, et al. Increased loss of decreased synthesis of hepatic glutathione after acute ethanol administration. Biochem J 1985;225:565–72.
   PubMed Web of Science ®Google Scholar
• Hirano T, Kaplowitz N, Tsukamoto H, et al. Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats. Hepatology 1992;6:1423–7.
   Google Scholar
• Gebhardt AC, Lucas D, Menez JF, et al. Chlormethiazole inhibition of cytochrome P450 2E1 as assessed by chlorzoxazone hydroxylation in humans. Hepatology 1997;26:957–61.
   PubMed Web of Science ®Google Scholar
• Fang C, Lindros KO, Badger TM, et al. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology 1998;27:1304–10.
   PubMedGoogle Scholar
• Eap CB, Schnyder C, Besson J, et al. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers. Clin Pharmacol Ther 1998;64:52–7.
   PubMed Web of Science ®Google Scholar
• French S, Morimoto M, Reitz R, et al. Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats. J Nutr 1997;127:907S-911S.
   Google Scholar
• Kim ND, Kwak MK, Kim SG. Inhibition of cytochrome P450 2E1 expression by 2-(allylthio) pyrazine, a potential chemoprotective agent: hepatoprotective effects. Biochem Pharmacol 1997;53:261–9.
   PubMed Web of Science ®Google Scholar
• Morimoto M, Hagbjork AL, Nanji AA, et al. Role of cytochrome P450 2E1 in alcoholic liver disease pathogenesis. Alcohol 1993;10:459–64.
   PubMed Web of Science ®Google Scholar
• Morimoto M, Hagbjork AL, Wan YJY, et al: Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors. Hepatology 1995;21:1610–17.
   PubMed Web of Science ®Google Scholar
• Mathews, JM, Etheridge AS, Raymer JH, et al. Selective inhibition of cytochrome P450 2E1 in vivo and in vitro with trans-1,2-dichloroethylene. Chem Res Toxicol 1998;11:778–85.
   PubMed Web of Science ®Google Scholar
• Aleynik MK, Leo MA, Aleynik SI, et al. Polyenylphosphatidylcholine opposes the increase of cytochrome P4502E1 by ethanol and corrects its iron-induced decrease. Alcohol: Clin Exp Res 1999;23:96–100.
   PubMed Web of Science ®Google Scholar
• Lefevre A, DeCarli LM, Lieber CS. Effect of ethanol on cholesterol and bile acid metabolism. J Lipid Res 1972;13:48–55.
   PubMedGoogle Scholar
• Vendemiale G, Jayatilleke E, Shaw S, et al: Depression of biliary glutathione excretion by chronic ethanol feeding in the rat. Life Sci 1984;34:1065–73.
   PubMed Web of Science ®Google Scholar
• Vendemiale G, Grattagliano I, Signorile A, et al. Ethanol-induced changes of intracellular thiol compartmentation and protein redox status in the rat liver: effect of tauroursodeoxycholate. J Hepatology 1998;28:46–53.
   PubMed Web of Science ®Google Scholar
• Plevris JN, Hayes PC, Bouchier IAD: Ursodeoxychoic acid in the treatment of alcoholic liver disease. Eur J Gastroenterol Hepatol 1991;3:653–6.
   Google Scholar
• Kerai MD, Waterfield CJ, Kenyon SH, et al. Taurine: protective properties against ethanol-induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats. Amino Acids 1998;15:53–76.
   PubMed Web of Science ®Google Scholar
• Tabouy L, Zamora AJ, Oliva L, et al. Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury. Life Sci 1998;63:2259–70.
   PubMedGoogle Scholar
• Oliva L, Beauge F, Choquart D, et al. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats. Alcohol Clin Exp Res 1998;22:1538–43.
   PubMedGoogle Scholar
• Neuman MG, Cameron RG, Shear NH, et al. Effects of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human hep G2 cell line. Gastroenterol 1995;109:555–63.
   PubMedGoogle Scholar
• von Herbay A, de Groot H, Hegi U, et al: Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J Hepatology 1994;20:41–6.
   PubMed Web of Science ®Google Scholar
• Zhang H, Loney LA, Potter BJ. Effect of chronic alcohol feeding on hepatic iron status and ferritin uptake by rat hepatocytes. Alcohol: Clin Exp Res 1993;17:394–400.
   PubMed Web of Science ®Google Scholar
• Valenzuela A, Fernandez V, Videla LA. Hepatic and biliary levels of glutathione and lipid peroxides following iron overload in the rat: Effect of simultaneous ethanol administration. Toxicology and Applied Pharmacology, 1983;70:87–95.
   PubMed Web of Science ®Google Scholar
• Lieber CS, DeCarli LM, Schmid R: Effects of ethanol on fatty acid metabolism in liver slices. Biochem Biophys Res Comm 1959;1:302–6.
   Google Scholar
• Lieber CS, Spritz N, DeCarli LM: Role of dietary, adipose and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest 1966;45:51–62.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Spritz N: Effects of prolonged ethanol intake in man: Role of dietary, adipose, and endogenously synthesized fatty acids in the pathogenesis of the alcoholic fatty liver. J Clin Invest 1966;45:1400–11.
   PubMed Web of Science ®Google Scholar
• Lieber CS, DeCarli LM: Quantitative relationship between the amount of dietary fat and the severity of the alcoholic fatty liver. Am J Clin Nutr 1970;23:474–8.
   PubMed Web of Science ®Google Scholar
• Lieber CS, DeCarli LM: Study of agents for the prevention of the fatty liver produced by prolonged alcohol intake. Gastroenterology 1966;50:316–22.
   PubMed Web of Science ®Google Scholar
• Lieber CS, Lefevre A, Spritz N, et al. Difference in hepatic metabolism of long and medium-chain fatty acids: The role of fatty acid chain length in the production of the alcoholic fatty liver. J Clin Invest 1967;46:1451–60.
   PubMed Web of Science ®Google Scholar
• Nanji AA, Yang EK, Fogt F, et al. Medium Chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol Exp Ther 1996;277:1694–700.
   PubMedGoogle Scholar
• Maddrey WC, Roftnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatis. Gastroenterology 1978;75:193–9.
   PubMed Web of Science ®Google Scholar
• Carithers RL Jr, Henong F, DienI AM, et al: Methylprednisolone therapy in patients with severe alcoholic hepatitis: A randomized multicenter trial. Ann Intern Med1989;110:685–90.
   Google Scholar
• Lieber CS, Lefevre A, Luffman F: The effect of prednisolone on the increased blood ammonia level in Eck fistula dogs. Rev Belg Pathol 1958;26:414–25.
   Google Scholar
• Imperiale TF, McCullough AJ: Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. Ann Intern Med 1990;299-307.
   Google Scholar
• Ramond M-J, Poynard T, Rueff S. et al: A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507–12.
   PubMed Web of Science ®Google Scholar
• Trinchet JC, Balkau S, Poupon RE, et al. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial. Hepatology 1992;15:76–81.
   PubMed Web of Science ®Google Scholar
• Nolan JP. Intestinal Endotoxins as Mediators of Hepatic Injury-An Idea Whose Time Has Come Again. Hepatology 1989;10:887–91.
   PubMed Web of Science ®Google Scholar
• Nolan JP, Camara DS. Intestinal endotoxins as co-factors in liver injury. Immunol. Invest. 1989;18:325–37.
   PubMed Web of Science ®Google Scholar
• Adachi Y, Moore LE, Bradford BU, et al. Antibiotics prevent liver injury in rats following long term exposure to ethanol. Gastroenterology 1995;108:218–24.
   PubMed Web of Science ®Google Scholar
• Decker K. Biologically active products of stimulated liver macrophages (Kupffer Cells) J. Biochem 1990;192:245–61.
   Google Scholar
• Matsuoka M, Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 1990;11:599–605.
   PubMed Web of Science ®Google Scholar
• Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995;22:1304–09.
   PubMed Web of Science ®Google Scholar
• Bautista AP. The role of Kupffer cells and reactive oxygen species in hepatic injury during acute and chronic alcohol intoxication. Alcohol: Clin Exp Res 1998;22:255S–259S.
   Google Scholar
• Batey R, Cao Q, Madsen G, et al. Decreased tumor necrosis factor- and interleukin-1 production from intrahepatic mononuclear cells in chronic ethanol consumption and up regulation by endotoxin. Alcohol: Clin Exp Res 1998;22:150–6.
   PubMedGoogle Scholar
• Tsukamoto H. Molecular mechanism of induced hepatic macrophage cytokine gene expression in experimental alcoholic liver injury. Alcohol: Clin Exp Res 1998;22:253S–254S.
   Google Scholar
• Oneta CM, Mak KM, Lieber CS. Dilinoleoylphosphatidylcholine selectively modulates lipopolysaccharide-induced Kupffer cell activation. J Lab Clin Med 1999;134:466–70.
   PubMed Web of Science ®Google Scholar
• Cao Q, Mak KM, Lieber CS. Dilinoleoylphosphatidylcholine (DLPC) decreases TNF-generation in acetaldehyde (ACH)-or lipopolysaccharide (LPS)-activated Kupffer cells of ethanol-fed rats. Alcohol: Clin Exp Res 2000;24: 130A.
   Google Scholar
• Neuman MG. First International Symposium on the Molecular Pathology and Clinical Aspects of the Inflamed Liver: Alcohol and Cytokines. Clin Invest Med 1998;21:283–6.
   Google Scholar
• McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in Alcoholic Liver Disease. Seminars in Liver Disease 1999;19:205–21.
   Google Scholar
• Paronetto F: Immunologic reactions in alcoholic liver disease. In: (CS Lieber, Editor) Medical and Nutritional Complications of Alcoholism: Mechanisms and Management. Plenum Press, New York, NY, 1992, p 283–305.
   Google Scholar
• Falchuk KR, Fiske S, Federman C, et al. Pericentral hepatic fibrosis and intracellular hyaline in diabetes mellitus. Gastroenterology 1980;78:535–41.
   PubMedGoogle Scholar
• Feinman L, Lieber CS. Hepatic collagen metabolism: effect of alcohol consumption in rats and baboons. Science 1972;176: 795.
   PubMed Web of Science ®Google Scholar
• Patrick RS. Alcohol as a stimulus to hepatic fibrogenesis. J Alcoholism 1973;8:13–27.
   Google Scholar
• Mezey E, Potter JJ, Iber FL, et al. Hepatic collagen proline hydroxylase activity in alcoholic hepatitis: effect of d-penicillamine. J Lab Clin Med 1979;93:92–100.
   PubMedGoogle Scholar
• Ma X, Svegliati-Baroni G, Poniachik J, et al: Collagen synthesis by liver stellate cells is released from its normal feedback regulation by acetaldehyde-induced modification of the carboxyl-terminal propeptide of procollagen. Alcohol: Clin Exp Res 1997;21;1204-11.
   Google Scholar
• Poniachik J, Baraona E, Zhao J, et al. Dilinoleoylphosphatidylcholine decreases hepatic stellate cell activation. J Lab Clin Med 1999;133:342–8.
   PubMedGoogle Scholar
• Geesin JC, Hendricks LJ, Falkenstein PA, et al: Regulation of collagen synthesis by ascorbic acid: Characterization of the role of ascorbate stimulated lipid peroxidation. Arch Biochem Biophys 1991;290:127–32.
   PubMed Web of Science ®Google Scholar
• Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol 1993;10:465–7.
   PubMedGoogle Scholar
• Kershenobich D, Vargas F, Garcia-Tsao G, et al. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988;318:1709–13.
   PubMed Web of Science ®Google Scholar
• Boyer LJ, Ransohoff FD: Is colchicine effective therapy for cirrhosis? N Engl J Med 1988;318:1751–2.
   PubMedGoogle Scholar
• Rosman AS, Waraich A, Galvin K, et al: Alcoholism is associated with hepatitis C but not hepatitis B in an urban population, Am J Gastroenterol 1996;91:498–505.
   Google Scholar
• Consensus Conference: Liver transplantation. JAMA 1983;250:2961–4.
   Google Scholar
• Bird GLA, O'Grady JG, Harvey FAH, et al: Liver transplantation in patients with alcoholic cirrhosis: Selection criteria and rates of survival and relapse. BMJ 1990;301:15–17.
   PubMed Web of Science ®Google Scholar
• Osorio RW, Ascher NL, Avery M, et al. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20:105–10.
   PubMed Web of Science ®Google Scholar
• Lucey MR, Merion RM, Henley KS, et al: Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 1992;102:1736–41.
   PubMed Web of Science ®Google Scholar
• Bonet H, Manez R, Kramer D, et al: Liver transplantation for alcoholic liver disease: Survival of patients transplanted with alcoholic hepatitis plus cirrhosis as compared with those with cirrhosis alone. Alcohol: Clin Exp Res 1993;17:1102–6.
   PubMed Web of Science ®Google Scholar